Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?

European Journal of Clinical Investigation

Volumn 42, Issue 5, 2012, Pages 478-486

  Carpagnano, Giovanna E ^a   Lacedonia, Donato ^a   Palladino, Grazia P ^a   Koutelou, Anna ^a   Martinelli, Domenico ^a   Orlando, Silvio ^b   Foschino Barbaro, Maria P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Apulia Regional Epidemiological Observatory ^*  (Italy)

Author keywords

Breath condensate; Ferritin; Lung cancer; Superoxide dismutase

Indexed keywords

FERRITIN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXHALED BREATH CONDENSATE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS;

AGED; BREATH TESTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; EXHALATION; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859732005     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02603.x     Document Type: Article

References (42)

1. Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K et al. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther 2007;7:1405-21.
2. Carpagnano GE, Spanevello A, Palladino GP, Gramiccioni C, Ruggieri C, Carpagnano F et al. Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link? Lung Cancer 2010;67:108-13.
3. Carpagnano GE, Spanevello A, Curci C, Salerno F, Palladino GP, Resta O et al. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol Res 2007;16:375-81.
4. Macchia V, Mariano A, Cavalcanti M, Coppa A, Cecere C, Fraioli G et al. Tumor markers and lung cancer: correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. Int J Biol Markers 1987;2:151-6.
5. Nelson ME, O'Brien-Ladner AR, Wesselius LJ. Regional variation in iron and iron-binding proteins within the lungs of smokers. Am J Respir Crit Care Med 1996;153(4 Pt 1):1353-8.
6. Fracchia A, Ubbiali A, El Bitar O, Pacetti M, Sommariva E, Arreghini M et al. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects. Oncology 1999;56:181-8.
7. Cox R, Gyde OH, Leyland MJ. Serum ferritin levels in small cell lung cancer. Eur J Cancer Clin Oncol 1986;22:831-5.
8. Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z, Poljak-Blazi M. Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med Oncol 2010;27:268-77.
9. Franciolli M, Rosenmund A. Iron and iron-binding proteins in the differential diagnosis of pleural effusion. Schweiz Med Wochenschr 1989;119:785-90.
10. Stites SW, Walters B, O'Brien-Ladner AR, Bailey K, Wesselius LJ. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 1998;114:814-9.
11. Wesselius LJ, Nelson ME, Skikne BS. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med 1994;150:690-5.
12. Stites SW, Nelson ME, Wesselius LJ. Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS. Chest 1995;107:1681-5.
13. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986;246:501-14.
14. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994;12:289-303.
15. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417-27.
16. Gutteridge JM, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta 1992;1159:248-54.
17. Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009;4:172-8.
18. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003;167:1600-19.
19. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 1995;73:3-19.
20. Crapo JD, Tierney DF. Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 1974;226:1401-7.
21. Chung-man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001;61:8578-85.
22. Durak I, Canbolat O, Kavutçu M, Oztürk HS, Yurtarslani Z. Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996;10:17-20.
23. Zaleska M, Szturmowicz M, Zych J, Roszkowska-Sliz B, Demkow U, Langfort R et al. Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse serviva. Pneumonol Alergol Pol 2010;78:14-20.
24. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP et al. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology 2010;15:349-56.
25. Carpagnano GE, Palladino GP, Gramiccioni C, Foschino Barbaro MP, Martinelli D. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients. Lung Cancer 2010;68:305-7.
26. Carpagnano GE, Spanevello A, Carpagnano F, Palladino GP, Prato R, Martinelli D et al. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Lung Cancer 2009;64:334-40.
27. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008;177:337-41.
28. Carpagnano GE, Foschino-Barbaro MP, Mulé G, Resta O, Tommasi S, Mangia A et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:738-44.
29. Carpagnano GE, Foschino-Barbaro MP, Resta O, Gramiccioni E, Carpagnano F. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004;66:180-4.
30. Carpagnano GE, Resta O, Foschino-Barbaro MP, Gramiccioni E, Carpagnano F. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int J Biol Markers 2002;17:141-5.
31. Chen JT, Chen YC, Wang YC, Tseng RC, Chen CY, Wang YC. Alterations of the p16INK4A gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002;98:724-31.
32. Fleming ID, Cooper JS, Henson DE, Hutter RPV, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW. American Join Committee on Cancer Staging Handbook, 5th edn. Philadelphia: Lipincott-Raven, 1998: pp 117-29.
33. Vlasić Z, Dodig S, Cepelak I, Topić RZ, Zivcić J, Nogalo B et al. Iron and ferritin concentrations in exhaled breath condensate of children with asthma. J Asthma 2009;46:81-5.
34. Mutti A, Corradi M, Goldoni M, Vettori MV, Bernard A, Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006;129:1288-97.
35. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085-7.
36. 2. J Appl Physiol 1993;75:1256-62.
37. Kinnula VL, Yankaskas JR, Chang L, Virtanen I, Linnala A, Kang BH et al. Primary and immortalized (BEAS 2B) human bronchial epithelial cells have significant antioxidative capacity in vitro. Am J Respir Cell Mol Biol 1994;11:568-76.
38. Lakari E, Pääkkö P, Kinnula VL. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 1998;158:589-96.
39. Milman N, Pedersen LM. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep 2002;9:193-8.
40. Milman N, Sengeløv H, Dombernowsky P. Iron status markers in patients with small cell carcinoma of the lung. Relation to survival. Br J Cancer 1991;64:895-8.
41. Iwasaki M, Ogawa J, Inoue H, Kijima H, Watanabe K. Immunohistochemical properties of lipid peroxidation and prognosis in adenocarcinoma of the lung. J Cardiovasc Surg (Torino) 1998;39:233-6.
42. Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A, Belarmino J et al. Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 2007;67:10260-7.